Patients With Early-Phase Schizophrenia Will Accept Treatment With Sustained-Release Medication (Long-Acting Injectable Antipsychotics)
Year: 2019
Type: article
DOI: 10.4088/jcp.18m12546
Institutions: Feinstein Institute for Medical Research, Donald & Barbara Zucker School of Medicine at Hofstra/Northwell, Zucker Hillside Hospital, SUNY Downstate Health Sciences University, Vanguard (United States), Grand Rapids Public Library, Michigan State University, Charité – Universitätsmedizin Berlin
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2940449852
